跳至主要内容
临床试验/EUCTR2008-006309-17-LT
EUCTR2008-006309-17-LT进行中(未招募)不适用

Significance of prognostic and predictive factors for the efficacy and safety of neoadjuvant chemotherapy in combination with chemoradiation administered in patients with locally advanced cervical cancer.

KONSTANTINAS POVILAS VALUCKAS, INSTITUTE OF ONCOLOGY OF VILNIUS UNIVERSITY0 个研究点开始时间: 2009年6月19日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • 1. Women with locally advanced non-operable IIB-IIIB stages cervical cancer.
  • 2. Subjects previously received no treatment for cervical cancer.
  • 3. Age 18-60 years.
  • 4. ECOG = 0, ECOG = 1.
  • 5. Written informed consent form.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Unstable angina pectoris or myocardial infarction within 6 months prior to enrolment; life threatening cardiac arrhythmia and not finished supportive therapy; known pulmonary hypertension.
  • 2. Non-adequate laboratory analysis values:
  • ANC< 1,5x10*/l; Plt < or = 100x10*/l; Hb < or= 90 g/l;
  • serum creatinine > or= upper limit of normal (ULN); ALT and AST > or = 3x ULN.
  • 3. Pregnancy or breast-feeding period;
  • 4. Serious psychiatric disorders.

研究者

发起方
KONSTANTINAS POVILAS VALUCKAS, INSTITUTE OF ONCOLOGY OF VILNIUS UNIVERSITY

相似试验